Contemporary indications for and outcomes of hepatic resection for neuroendocrine liver metastases

Table 2 Postoperative outcomes of patients with neuroendocrine liver metastases undergoing liver resection

	NELM (n = 669)
Post-hepatectomy
Bile leakage, n (%)	40 (5.9)
Post hepatectomy invasive intervention, n (%)	65 (9.7)
Post hepatectomy liver failure, n (%)	18 (2.6)
Specific complications
Superficial surgical site infection, n (%)	24 (3.5)
Deep incisional surgical site infection, n (%)	4 (0.6)
Organ/space surgical site infection, n (%)	49 (7.3)
Bleeding requiring transfusion, n (%)	104 (15.5)
Unplanned re-intubation, n (%)	9 (1.3)
Pneumonia, n (%)	20 (2.9)
Pulmonary embolism, n (%)	14 (2)
Progressive renal insufficiency, n (%)	7 (1.1)
Urinary tract infection, n (%)	14 (2)
Stroke, n (%)	1 (0.1)
Cardiac arrest, n (%)	2 (0.3)
Myocardial infarction, n (%)	3 (0.4)
Deep venous thrombosis/thrombophlebitis, n (%)	9 (1.4)
Sepsis, n (%)	38 (5.6)
Overall
Median length of hospital stay in days, n (IQR)	6 (4-8)
Discharge destination to home, n (%)	637 (95.2)
30-d readmission, n (%)	75 (11.2)
Reoperation, n (%)	21 (3.1)
30-d overall morbidity, n (%)	194 (29)
Mortality, n (%)	9 (1.3)

NELM: Neuroendocrine liver metastases; IQR: Interquartile range.